...
首页> 外文期刊>Archives of Oral Biology >Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a rat model
【24h】

Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a rat model

机译:新型生物降解的壳聚糖基于二甲双胍库内牙科胶片的发展与评价,用于牙周炎和大鼠肺泡骨质损失

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Highlights ? Chitosan-based metformin intrapocket dental films (CMIDF) were fabricated. ? CMIDF inserts were tested in rat model of periodontitis. ? CMIDF showed antibacterial activity and improved alveolar bone properties. Abstract Objective The aim of this study was to develop a chitosan-metformin based intrapocket dental film (CMIDF) for applications in the treatment of periodontitis and alveolar bone loss in an rat model of periodontitis. Design CMIDF inserts were fabricated by the solvent casting technique. The fabricated inserts were evaluated for physical characteristics such as folding endurance, surface pH, mucoadhesive strength, metformin content uniformity, and release. X-ray diffraction analysis indicates no crystallinity of metformin in presence of chitosan which confirmed successful entrapment of metformin into the CMIDF. Fourier-transform infrared spectroscopy revealed stability of CMIDF and compatibility between metformin and chitosan. Periodontitis was induced by a combination of Porphyromonas gingivalis - lipopolysaccharide injections in combinations with ligatures around the mandibular first molar. We divided rats into 5 groups (8 rats/group): healthy, untreated periodontitis; periodontitis plus CMIDF-A (1.99±0.09mg metformin; total mass-4.01±0.05mg), periodontitis plus CMIDF-B (2.07±0.06mg metformin; total mass-7.56±0.09mg), and periodontitis plus chitosan film (7.61±0.08mg). After four weeks, mandibles were extracted to evaluate alveolar bone loss by micro-computerized tomography and histological techniques. Results Alveolar bone was intact in the healthy group. Local administration of CMIDF resulted in significant improvements in the alveolar bone properties when compared to the untreated periodontitis group. The study reported here demonstrates that novel CMIDF showed good antibacterial activity and effectively reduced alveolar bone destruction in a rat model of experimental periodontitis. Conclusions Novel CMIDF showed good antibacterial activity and improved alveolar bone properties in a rat model.
机译:图形抽象显示省略了亮点?制造壳聚糖的二甲双胍牙科胶膜(CMIDF)。还在牙周炎大鼠模型中测试CMIDF插入物。还CMIDF显示抗菌活性和改善的肺泡骨性质。摘要本研究的目的是开发基于壳聚糖 - 二甲双胍的内部牙科胶片(CMIDF),用于治疗牙周炎大鼠牙周炎和肺泡骨质损失的应用。设计CMIDF插入物由溶剂铸造技术制造。评估制造的插入物,用于物理特性,例如折叠耐久性,表面pH,粘膜粘附强度,二甲双胍含量均匀性和释放。 X射线衍射分析表明在壳聚糖存在下没有二甲双胍的结晶度,其证实了二甲双胍的成功夹在CMIDF中。傅立叶变换红外光谱显示CMIDF的稳定性和二甲双胍与壳聚糖之间的相容性。牙周炎致牙耳炎牙龈炎 - 脂多糖中的组合诱导与下颌第一摩尔周围的结扎物组合。我们将大鼠分成5组(8只大鼠/组):健康,未经治疗的牙周炎;牙周炎加上CMIDF-A(1.99±0.09mg二甲双胍;总质量-4.01±0.05mg),牙周炎加上CMIDF-B(2.07±0.06mg二甲双胍;总质量-7.56±0.09mg)和牙周炎加上壳聚糖膜(7.61± 0.08mg)。四周后,提取颌骨以评价微量计算机断层扫描和组织技术的肺泡骨损伤。结果肺泡骨在健康组中完整。与未处理的牙周炎组相比,CMIDF的局部施用导致肺泡骨质性质的显着改善。本研究报告在此证明了新型CMIDF显示出良好的抗菌活性,并有效地降低了实验期牙周炎大​​鼠模型中的肺泡骨破坏。结论新型CMIDF在大鼠模型中显示出良好的抗菌活性和改善的肺泡骨特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号